Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer
Kirstine Jacobsen(University of Southern Denmark), Rafael Rosell(Instituto Oncológico Dr. Rosell)
Cited by 182
Related Papers
Liquid Biopsy in Non-Small Cell Lung Cancer
|Frontiers in Medicine|2016|66
Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC)
|Oncotarget|2017|49
Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines
|Translational Lung Cancer Research|2019|17
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer
|Lung Cancer Targets and Therapy|2024|5